Hisamitsu Pharmaceutical Co (FSE:4530) FCF Margin %: 0.00% (As of Nov. 2025)


FSE:4530 Hisamitsu Pharmaceutical Co Inc FSE:4530
89 GF Score
Price 円3,975.00
GF Value 円3,237.07
View Full Analysis

What is Hisamitsu Pharmaceutical Co FCF Margin %?

Hisamitsu Pharmaceutical Co FSE:4530 89 FCF Margin % is 0.00% as of Nov. 2025. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07. Among 958 Drug Manufacturers companies, Hisamitsu Pharmaceutical Co ranks better than 58.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hisamitsu Pharmaceutical Co's Free Cash Flow for the three months ended in Nov. 2025 was 円0 Mil. Hisamitsu Pharmaceutical Co's Revenue for the three months ended in Nov. 2025 was 円39,571 Mil. Therefore, Hisamitsu Pharmaceutical Co's FCF Margin % for the quarter that ended in Nov. 2025 was 0.00%.

As of today, Hisamitsu Pharmaceutical Co's current FCF Yield % is 2.22%.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's FCF Margin % or its related term are showing as below:

FSE:4530' s FCF Margin % Range Over the Past 10 Years
Min: 1.66   Med: 7.11   Max: 18.26
Current: 5.78


During the past 13 years, the highest FCF Margin % of Hisamitsu Pharmaceutical Co was 18.26%. The lowest was 1.66%. And the median was 7.11%.

FSE:4530's FCF Margin % is ranked better than
58.56% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs FSE:4530: 5.78


Hisamitsu Pharmaceutical Co FCF Margin % Related Terms


Hisamitsu Pharmaceutical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co FCF Margin % Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.48 3.76 3.64 3.20 5.78

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FSE:4530 vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's FCF Margin % falls into.


FSE:4530
89GF Score
Hisamitsu Pharmaceutical Co Inc FSE:4530
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hisamitsu Pharmaceutical Co's FCF Margin for the fiscal year that ended in Feb. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Feb. 2026 )/Revenue (A: Feb. 2026 )
=9428/163024
=5.78 %

Hisamitsu Pharmaceutical Co's FCF Margin for the quarter that ended in Nov. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Nov. 2025 )/Revenue (Q: Nov. 2025 )
=0/39571
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Hisamitsu Pharmaceutical Co (FSE:4530) has a FCF Margin % of 0.00% as of Nov. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Over the past decade, Hisamitsu Pharmaceutical Co's FCF Margin % has ranged from 1.66 to 18.26. According to the industry distribution chart, Hisamitsu Pharmaceutical Co ranks #397 out of 958 companies in the Drug Manufacturers industry, placing it in the top 41.4%.
Is Hisamitsu Pharmaceutical Co's FCF Margin % too high?
Hisamitsu Pharmaceutical Co's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 1.66 to a high of 18.26. Based on the distribution chart, Hisamitsu Pharmaceutical Co ranks #397 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hisamitsu Pharmaceutical Co ranks #397 out of 958 companies for FCF Margin %. This puts Hisamitsu Pharmaceutical Co in the upper half of its industry. The industry median FCF Margin % is 2.51. Historically, Hisamitsu Pharmaceutical Co's own FCF Margin % has ranged from 1.66 to 18.26 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hisamitsu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hisamitsu Pharmaceutical Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current FCF Margin % of 0.00%. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current FCF Margin % is 0.00%. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current FCF Margin % is 0.00% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.

Key valuation signals for FSE:4530:

  • FCF Margin %: 0.00%
  • GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
  • GF Score™: 89/100

No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score

Get the complete analysis for FSE:4530

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,975.00
Price
円3,237.07
GF Value